KARACHI: Doctors at Jinnah Hospital have successfully carried out the hospital’s first-ever knee cancer operation, giving a 26-year-old patient a new lease of life with the implantation of an artificial knee, ARY News reported.
According to Dr Farukh, the young patient was suffering from cancer in his knee and lower leg. A four-hour-long surgery was conducted by a team of orthopaedic and plastic surgeons at Jinnah Hospital, Karachi, during which the cancer was removed and a prosthetic knee was implanted.
Dr Farukh confirmed that all post-operation tests came back normal and there is now no trace of cancer in the patient’s body. He added that the artificial knee, which usually costs between Rs1 million to Rs1.1 million, was provided free of cost by the Jinnah Hospital, Karachi.
Globally, such artificial knees remain effective for 20 to 25 years, ensuring long-term mobility for patients. The procedure, worth an estimated Rs3.5 million, was conducted entirely free of charge.
The surgery team included Dr Farukh, Dr Muzaffar, Dr Wali, Dr Shahid and Dr Khushal, while the plastic surgery team comprised Dr Agha Waseem, Dr Mehak, Dr Komal and Dr Farooq.
Earlier, Pakistan successfully developed a vaccine aimed at preventing breast cancer.
As per details, the Institute of Public Health Punjab has developed the vaccine to prevent breast cancer among females.
A policy dialogue has been initiated regarding the production of the Human Papillomavirus vaccine, which experts say could prove to be a milestone in the country’s healthcare sector.
Also Read: Pakistan develops first-ever vaccine for breast cancer prevention
Commenting on the development, Punjab Finance Minister Mujtaba Shuja said that the provincial government is paying special attention to the health sector, adding that the development of the Papilloma Vaccine by the Institute of Public Health is a remarkable achievement.
Renowned medical expert Professor Dr. Javed Akram said the vaccine would help in the prevention of breast cancer.
He explained that administering three doses of the vaccine to girls at the age of 12 would provide lifelong protection against the disease.